Position in RDNT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,283,327
+$4,786,203 QoQ
Shares Held
291,346
+80.8% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 57%
Shared 43%
None 0%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PALISADE CAPITAL MANAGEMENT, LP holds $70,717,565 across 5 Diagnostics & Research names. RDNT ranks #2 (23.0% of the industry book) .
All Filings in RDNT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,283,327 | 291,346 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,497,124 | 161,137 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,714,294 | 179,954 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,346,977 | 181,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,986,450 | 80,178 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||